Additionally, GLP-1 receptor agonists slow gastric emptying, which prolongs the feeling of fullness after eating, and they act on appetite centres in the hypothalamus to reduce hunger and food intake
Jesuit Missions of the Chiquitania
Key Points Semaglutide is not FDA-approved to treat PCOS Some studies, however, show that semaglutide helped women with PCOS lose weight Weight loss often helps PCOS symptoms by reducing insulin resistance and hormonal imbalances Proper nutrition plays a key role in managing PCOS PCOS carries serious long-term health consequences, including an increased risk of diabetes, heart disease, and fertility challenges
Severe or persistent dizziness is uncommon and often signals the need for a dose adjustment or medication change
10.1016/j.clinre.2013.10.013 59
Breastfeeding is not recommended during treatment with Wegovy tablets